| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/20/2023 | 309.84% | HC Wainwright & Co. | $9 → $5 | Maintains | Buy |
| 09/26/2023 | 637.7% | Cantor Fitzgerald | → $9 | Reiterates | Overweight → Overweight |
| 09/22/2023 | 637.7% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 09/14/2023 | 637.7% | Cantor Fitzgerald | → $9 | Reiterates | Overweight → Overweight |
| 08/22/2023 | 637.7% | Cantor Fitzgerald | → $9 | Reiterates | Overweight → Overweight |
| 08/18/2023 | 473.77% | HC Wainwright & Co. | $10 → $7 | Reiterates | Buy → Buy |
| 06/01/2023 | 719.67% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 05/18/2023 | 883.61% | Cantor Fitzgerald | $15 → $12 | Maintains | Overweight |
| 04/27/2023 | 719.67% | HC Wainwright & Co. | $25 → $10 | Maintains | Buy |
| 03/30/2023 | 1949.18% | HC Wainwright & Co. | → $25 | Reiterates | → Buy |
| 02/16/2023 | 1949.18% | HC Wainwright & Co. | → $25 | Reiterates | → Buy |
| 02/10/2023 | 801.64% | JonesTrading | → $11 | Initiates Coverage On | → Buy |
| 10/25/2022 | 1129.51% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
| 06/21/2022 | 1949.18% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
What is the target price for Mainz Biomed (MYNZ)?
The latest price target for Mainz Biomed (NASDAQ: MYNZ) was reported by HC Wainwright & Co. on November 20, 2023. The analyst firm set a price target for $5.00 expecting MYNZ to rise to within 12 months (a possible 309.84% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mainz Biomed (MYNZ)?
The latest analyst rating for Mainz Biomed (NASDAQ: MYNZ) was provided by HC Wainwright & Co., and Mainz Biomed maintained their buy rating.
When is the next analyst rating going to be posted or updated for Mainz Biomed (MYNZ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mainz Biomed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mainz Biomed was filed on November 20, 2023 so you should expect the next rating to be made available sometime around November 20, 2024.
Is the Analyst Rating Mainz Biomed (MYNZ) correct?
While ratings are subjective and will change, the latest Mainz Biomed (MYNZ) rating was a maintained with a price target of $9.00 to $5.00. The current price Mainz Biomed (MYNZ) is trading at is $1.22, which is out of the analyst's predicted range.